| |
| |
Cardiovascular & Hematopoietic System
Haemotastic
|
|
|
| |
Haemostop
|
|
Indications
Control of haemorrhage associated with severe
fibrinolysis in haemorrhagic disease, haemoptosis, after operations or tooth
extraction
Pharmacology
Each HAEMOSTOP 500 mg caplet contains: Tranexamic Acid ………. 500 mg
Each ml of HAEMOSTOP 250 mg injection contains: Tranexamic Acid ……….. 50 mg
Each ml of HAEMOSTOP 250 mg injection contains: Tranexamic Acid ……….100 mg
Package Quantities
Box of 10 strips @ 10 caplets
Box of 5
ampoules @ 5 ml
Box
of 5 ampoules @ 5 ml
|
|
|
|
|